1 - 229 of 229
Title Published in Access level OA Policy Year Views Downloads
Alliance thérapeutique et thérapie cognitivo-comportementale de groupeRevue médicale suisse
2023 108 311
Relapses of Immune Thrombocytopenia after the Second and Booster Doses of BNT162b2 VaccineActa haematologica
2023 69 124
Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated with TramadolPharmaceuticals
2023 67 49
Medical cannabinoids for painful symptoms in patients with severe dementia: a randomized, double-blind cross-over placebo-controlled trial protocolFrontiers in pain research
2023 126 233
Is massage a legitimate part of nursing care ? A qualitative studyPloS one
2023 76 226
Joint Analysis of Phenotypic and Genomic Diversity Sheds Light on the Evolution of Xenobiotic Metabolism in HumansGenome biology and evolution
2022 537 229
Opioid‐related adverse drug reactions in patients visiting the emergency division of a tertiary hospitalPharmacology research & perspectives
2022 153 109
Hydromorphone Prescription for Pain in Children - What Place in Clinical Practice?Frontiers in pediatrics
2022 184 167
Case report: Confirming a diagnosis of severe olmesartan-associated enteropathyThérapie
2022 214 0
Dexamethasone for the treatment of established postoperative nausea and vomiting: A randomised dose finding trialEuropean journal of anaesthesiology
2022 371 289
Evaluation of CYP1A2 activity: Relationship between the endogenous urinary 6-hydroxymelatonin to melatonin ratio and paraxanthine to caffeine ratio in dried blood spotsClinical and translational science
2022 243 232
Dexamethasone exposure in normal-weight and obese hospitalized COVID-19 patients: An observational exploratory trialClinical and translational science
2022 153 133
Uncovering a Genetic Polymorphism Located in Huntingtin Associated Protein 1 in Modulation of Central Pain Sensitization Signaling PathwaysFrontiers in neuroscience
2022 419 175
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World SettingJournal of personalized medicine
2022 224 315
Genetic Susceptibility Toward Nausea and Vomiting in Surgical PatientsFrontiers in genetics
2022 241 213
Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patientsFrontiers in aging neuroscience
2022 89 160
Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokineticsCPT: pharmacometrics & systems pharmacology
2022 274 475
Impact of SARS-CoV-2 Infection (COVID-19) on Cytochromes P450 Activity Assessed by the Geneva CocktailClinical pharmacology and therapeutics
2021 211 199
Tapentadol Versus Tramadol: A Narrative and Comparative Review of Their Pharmacological, Efficacy and Safety Profiles in Adult PatientsDrugs
2021 251 577
Activité, décentration et restructuration cognitive dans la thérapie cognitivocomportementale. Éléments pour la pratique cliniqueRevue médicale suisse
2021 396 1,365
CYP450 Genotype-Phenotype Concordance Using the Geneva Micrococktail in a Clinical SettingFrontiers in pharmacology
2021 281 318
Prevalence of Polypharmacy and Inappropriate Medication in Adults With Intellectual Disabilities in a Hospital Setting in SwitzerlandFrontiers in Psychiatry
2021 317 488
The 1β-Hydroxy-Deoxycholic Acid to Deoxycholic Acid Urinary Metabolic Ratio: Toward a Phenotyping of CYP3A Using an Endogenous Marker?Journal of personalized medicine
2021 225 66
Opioïdes monoaminergiques : lequel choisir ?Revue médicale suisse
2021 181 210
Influence of Inflammation on Cytochromes P450 Activity in Adults: A Systematic Review of the LiteratureFrontiers in pharmacology
2021 220 804
Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activityBritish journal of pharmacology
2021 327 204
Simultaneous determination of melatonin and 6-hydroxymelatonin in human overnight urine by LC-MS/MSJournal of chromatography. B
2021 434 513
Impacts of touch massage on the experience of patients with chronic pain: a protocol for a mixed method studyComplementary therapies in clinical practice
2021 289 1
Impact of Inflammation on Cytochromes P450 Activity in Pediatrics: A Systematic ReviewClinical pharmacokinetics
2021 230 345
Reviewing Data Integrated for PBPK Model Development to Predict Metabolic Drug-Drug Interactions: Shifting Perspectives and Emerging TrendsFrontiers in pharmacology
2021 183 285
Cannabinoids and COVID-19Medical Cannabis and Cannabinoids
2020 256 197
Safety of the Geneva Cocktail, a Cytochrome P450 and P-Glycoprotein Phenotyping Cocktail, in Healthy Volunteers from Three Different Geographic OriginsDrug Safety
2020 722 396
Mise au point sur la prise en charge de la douleur chez les patients adultes atteints de déficience intellectuelleDouleur et analgésie
2020 63 2
Outcomes of drug exposition during pregnancy: Analysis from a teratology information serviceEuropean Journal of Obstetrics, Gynecology, and Reproductive Biology
2020 277 4
Impact of acute inflammation on cytochromes P450 activity assessed by the Geneva CocktailClinical Pharmacology and Therapeutics
2020 335 554
GABAergic modulation of secondary hyperalgesia: A randomized controlled 4-way crossover trial with the α2-subunit preferring GABA positive allosteric modulator, N-desmethyl-clobazam in healthy volunteersEuropean Journal of Pain
2020 257 1
Opioïdes chez les patients âgés: Faux-amis ?La gazette médicale - info@gériatrie
2020 251 1
The Role of Demoralization and Meaning in Life (DEMIL) in Influencing Suicidal Ideation Among Patients Affected by Chronic Pain: Protocol of a Single-Center, Observational, Case-Control StudyJMIR Research Protocols
2020 409 240
Deep proteomics and phosphoproteomics reveal novel biological pathways perturbed by morphine, morphine-3-glucuronide and morphine-6-glucuronide in human astrocytesJournal of Neuroscience Research
2020 315 2
Pain interventions in adults with intellectual disability: A scoping review and pharmacological considerationsEuropean Journal of Pain
2020 288 1
Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in ChildrenTherapeutic Drug Monitoring
2020 451 196
TOP-ID: a Delphi technique-guided development of a prescription and deprescription tool for adults with intellectual disabilitiesBMJ Open
2020 380 149
Gender Differences in Cardiovascular Pharmacotherapy-the Example of Hypertension: A Mini ReviewFrontiers in Pharmacology
2020 278 249
Evaluation of Phenotypic and Genotypic Variations of Drug Metabolising Enzymes and Transporters in Chronic Pain Patients Facing Adverse Drug Reactions or Non-Response to Analgesics: A Retrospective StudyJournal of Personalized Medicine
2020 357 107
Interaction between Fexofenadine and CYP Phenotyping Probe Drugs in Geneva CocktailJournal of Personalized Medicine
2019 478 321
Phenotyping of human CYP450 enzymes by endobiotics: current knowledge and methodological approachesClinical Pharmacokinetics
2019 425 3
Development of a predictive score for potentially avoidable hospital readmissions for general internal medicine patientsPLOS ONE
2019 396 299
Safety issues of pharmacological acute pain treatment in childrenClinical Pharmacology and Therapeutics
2019 408 4
A case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorderBMC Psychiatry
2019 522 1,394
Liquid Chromatography-Tandem Mass Spectrometry Method for Ticagrelor and its Active Metabolite Determination in Human Plasma: Application to a Pharmacokinetic StudyCurrent Analytical Chemistry
2019 471 1
Snapshot of proton pump inhibitors prescriptions in a tertiary care hospital in Switzerland: less is more?International Journal of Clinical Pharmacy
2019 324 495
Cytochrome P450 1A2 activity and incidence of thyroid disease and cancer after chronic or acute exposure to dioxinsBasic & Clinical Pharmacology & Toxicology
2019 470 4
Pourquoi proposer la thérapie cognitivo-comportementale dans les douleurs chroniques ?Revue médicale suisse
2019 493 608
Physiologically-based pharmacokinetic modeling for the prediction of CYP2D6-mediated gene-drug-drug interactionsCPT: pharmacometrics & systems pharmacology
2019 411 461
Perioperative intravenous low-dose ketamine for neuropathic pain after major lower back surgery: A randomized, placebo-controlled studyEuropean Journal of Pain
2019 400 2
Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modelingPediatric Research
2019 335 2
Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active MetabolitesClinical Pharmacokinetics
2018 737 843
Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical PerspectivesClinical Pharmacokinetics
2018 522 908
Gestion de la douleur aiguë chez les patients sous traitements de substitution aux opioïdesRevue médicale suisse
2018 683 470
Phenotypic Assessment of Drug Metabolic Pathways and P-Glycoprotein in Patients Treated With Antidepressants in an Ambulatory SettingJournal of Clinical Psychiatry
2018 490 0
Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp softwareBiopharmaceutics & Drug Disposition
2018 625 12
Genotype-sensitive reversible and time-dependent CYP2D6 inhibition in human liver microsomesBasic & Clinical Pharmacology & Toxicology
2018 513 867
When the Safe Alternative Is Not That Safe: Tramadol Prescribing in ChildrenFrontiers in Pharmacology
2018 558 641
Prescription des opioïdes chez les patients vulnérables : les enfants et les personnes âgées. Recommandations pratiquesRevue médicale suisse
2018 597 608
Severe and persistent morphine-induced respiratory depression associated with ATP-Binding Cassette Subfamily B Member 1 and catechol-O-methyltransferase genetic defects: A case reportEuropean Journal of Anaesthesiology
2018 445 372
Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study)BMC Pharmacology & Toxicology
2017 520 222
Impact of CYP2D6 functional allelic variations on phenoconversion and drug-drug interactionsClinical Pharmacology and Therapeutics
2017 496 5
Characterization of oxycodone in vitro metabolism by human cytochromes P450 and UDP-glucuronosyltransferasesJournal of pharmaceutical and biomedical analysis
2017 662 852
Screening for genotypic and phenotypic variations in CYP450 activity in patients with therapeutic problems in a psychiatric setting, a retrospective studyPharmacological research
2017 661 187
"Late" Withdrawal Syndrome after Carbamazepine In Utero Exposure in a CYP2C9 Slow Metabolizer NewbornFrontiers in Pharmacology
2017 636 245
Impact d'une réconciliation médicamenteuse par un pharmacien lors de l'admission dans un service de médecine interneLe Pharmacien Hospitalier et Clinicien
2017 291 246
Hepatocyte Concentrations of Indocyanin Green (ICG) Reflects Transfer Rates Across Membrane TransportersBasic & clinical pharmacology & toxicology
2017 544 3
PIM-Check: development of an international prescription-screening checklist designed by a Delphi method for internal medicine patientsBMJ Open
2017 774 504
Usefulness of PBPK Modeling in Incorporation of Clinical Conditions in Personalized MedicineJournal of Pharmaceutical Sciences
2017 490 0
Meta-xylene: identification of a new antigenic entity in hypersensitivity reactions to local anestheticsJournal of allergy and clinical immunology. In practice
2016 663 1
Le coût, ce n'est pas tout…à propos des médicaments génériquesRevue médicale suisse
2016 451 3
Prescriptions médicamenteuses potentiellement inappropriées en gériatrie: quels outils utiliser pour les détecter?La Presse médicale
2016 634 8
Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic DefectFrontiers in pharmacology
2016 508 244
The clobazam metabolite N-desmethyl clobazam is an α2 preferring benzodiazepine with an improved therapeutic window for antihyperalgesiaNeuropharmacology
2016 591 322
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe : Preliminary ReportThe New England journal of medicine
2016 933 277
Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approachClinical pharmacology and therapeutics
2016 666 989
Pharmacogenomics of Oral Antithrombotic DrugsCurrent pharmaceutical design
2016 625 0
Intestinal permeability and P-glycoprotein-mediated efflux transport of ticagrelor in Caco-2 monolayer cellsFundamental & clinical pharmacology
2016 629 21
Severe Vincristine-Induced Neuropathic Pain in a CYP3A5 Nonexpressor With Reduced CYP3A4/5 Activity: Case StudyClinical therapeutics
2016 556 2
Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling MethodBasic & clinical pharmacology & toxicology
2016 679 820
Snapshot of the prescribing practice for the clopidogrel and esomeprazole coprescription and cost evaluation of the application guidelinesPharmacology research & perspectives
2016 698 353
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patientsMultiple sclerosis
2015 648 1
Markers of Individual Drug Metabolism: Towards the Development of a Personalized Antidepressant PrescriptionCurrent drug metabolism
2015 587 3
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trialLancet. Infectious diseases
2015 705 0
Prescribing Generic Medication in Chronic Musculoskeletal Pain Patients: An Issue of Representations, Trust, and Experience in a Swiss CohortPloS one
2015 601 302
Providing Quality Therapeutics in Switzerland: Role of the Stakeholders and Recent Incentives for Further ImprovementsClinical therapeutics
2015 715 6
Assessing the affective load in the narratives of women suffering from fibromyalgia: the clinicians' appraisalHealth expectations
2015 701 1
P-glycoprotein: a clue to vitamin K antagonist stabilizationPharmacogenomics
2015 702 0
A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-upJournal of neuroimmunology
2015 601 1
Evidence-Based Choice of P2Y12 Inhibitors in End Stage Renal Disease Patients: A Mini-ReviewCurrent drug metabolism
2015 644 6
Prescription d'antidépresseurs dans le traitement de la douleur : rôle de la pharmacogénétiqueRevue médicale suisse
2015 563 1
Cannabinoïdes médicaux dans les douleurs chroniques : aspects pharmacologiquesRevue médicale suisse
2015 693 5
Use of metamizole in children and the risk of agranulocytosis: Is the benefit worth the risk?European journal of anaesthesiology
2015 568 4
Drug-related problems identification in general internal medicine: The impact and role of the clinical pharmacist and pharmacologistEuropean journal of internal medicine
2015 736 6
Is pholcodine a dangerous cough suppressant?European journal of anaesthesiology
2015 627 1
GABAergic modulation in central sensitization in humans: a randomized placebo-controlled pharmacokinetic-pharmacodynamic study comparing clobazam with clonazepam in healthy volunteersPain
2015 626 3
Prediction by pharmacogenetics of safety and efficacy of non-steroidal anti- inflammatory drugs: a reviewCurrent drug metabolism
2014 656 0
Incorporation of Flurbiprofen in a 4-Drug Cytochrome P450 Phenotyping CocktailBasic & clinical pharmacology & toxicology
2014 648 4
Impact of clinical decision support guidelines on therapeutic drug monitoring of gentamicin in newbornsTherapeutic drug monitoring
2014 783 3
Snapshot of Prescribing Practice for Clopidogrel and Esomeprazole Co-Prescription and Cost Evaluation of Guidelines ApplicationValue in health
2014 517 240
Geneva Cocktail for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood SpotsClinical pharmacology and therapeutics
2014 926 512
Improving the primary care physicians' decision making for fibromyalgia in clinical practice: development and validation of the Fibromyalgia Detection (FibroDetect®) screening toolHealth and quality of life outcomes
2014 606 393
Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activityAIDS research and therapy
2014 738 966
Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic ModelCPT: pharmacometrics & systems pharmacology
2014 680 297
Simultaneous LC-MS/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasmaBioanalysis
2014 767 5
Central Pain Sensitization, COMT Val158Met Polymorphism, and Emotional Factors in FibromyalgiaThe journal of pain
2014 732 2
Identification and weighting of the most critical "real-life" drug-drug interactions with acenocoumarol in a tertiary care hospitalEuropean journal of clinical pharmacology
2013 876 802
Antihyperalgesic Effect of the GABA(A) Ligand Clobazam in a Neuropathic Pain Model in Mice: A Pharmacokinetic-Pharmacodynamic StudyBasic & clinical pharmacology & toxicology
2013 644 432
Role of P-glycoprotein in the uptake/efflux transport of oral vitamin K antagonists and rivaroxaban through the Caco-2 cell modelBasic & clinical pharmacology & toxicology
2013 601 3
Pharmacokinetic interaction between prasugrel and ritonavir in healthy volunteersBasic & clinical pharmacology & toxicology
2013 662 436
Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trialPain physician
2013 627 1,139
Influence of CYP2D6 activity on pre-emptive analgesia by the N-methyl-D-aspartate antagonist dextromethorphan in a randomized controlled trial of acute painPain physician
2013 793 751
Applications of CYP450 Testing in the Clinical SettingMolecular diagnosis & therapy
2013 771 975
Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatmentPharmacogenomics
2013 689 0
Primary attributions in women suffering fibromyalgia emphasize the perception of a disruptive onset for a long-lasting pain problemJournal of psychosomatic research
2013 680 956
Evaluation of anti-hyperalgesic and analgesic effects of two benzodiazepines in human experimental pain: a randomized placebo-controlled studyPloS one
2013 659 466
Transcriptional regulation of CYP2C19 and its role in altered enzyme activityCurrent drug metabolism
2012 608 0
Serotonin syndrome following drug-drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patientAIDS
2012 636 635
Psychological distress in fibromyalgia patients: a role for catechol-O-methyl-transferase Val158met polymorphismHealth psychology review
2012 828 695
Quel programme informatique de détection des interactions médicamenteuses néfastes ?Revue médicale suisse
2012 980 996
Representations of symptom history in women with fibromyalgia vs chronic low back pain: a qualitative studyPain medicine
2012 699 0
Effets indésirables des inhibiteurs de la pompe à proton: faut-il craindre de les prescrire au long cours ?La Revue de médecine interne
2012 766 2,049
Validation of the simplified UVB model to assess the pharmacodynamics of analgesics in healthy human volunteersChimia
2012 805 1,169
Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. A minireviewBasic & clinical pharmacology & toxicology
2012 653 751
Fracture atypique du fémur sous bisphosphonates, un effet indésirable à ne pas manquerRevue médicale suisse
2012 617 0
The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitroBritish journal of pharmacology
2012 591 0
Pharmacovigilance in pregnancy: adverse drug reactions associated with fetal disordersJournal of perinatal medicine
2012 756 1,464
Oral flurbiprofen metabolic ratio assessment using a single-point dried blood spotClinical pharmacology and therapeutics
2012 650 0
Analgesics in patients with hepatic impairment: pharmacology and clinical implicationsDrugs
2012 704 3
Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infectionJournal of viral hepatitis
2012 663 0
A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometryRCM. Rapid communications in mass spectrometry
2012 846 914
Rotation des opioïdes : de la théorie à la pratique Recommandations interdisciplinaires du réseau douleur des HUGRevue médicale suisse
2011 737 1
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipientsHaematologica
2011 1,053 635
Effet placebo analgésique : apport des neurosciencesRevue médicale suisse
2011 655 2
A randomized, controlled trial validates a peripheral supra-additive antihyperalgesic effect of a paracetamol-ketorolac combinationBasic & clinical pharmacology & toxicology
2011 678 0
Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug-drug interaction in HIV patientsMetabolism, clinical and experimental
2011 691 0
Le placebo, un allié mésestimé..Revue médicale suisse
2011 769 295
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center studyArthritis and rheumatism
2011 879 8
HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic painNeuropharmacology
2011 816 689
ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemiaPharmacogenomics
2011 954 6
Automated system for on-line desorption of dried blood spots applied to LC/MS/MS pharmacokinetic study of flurbiprofen and its metaboliteJournal of pharmaceutical and biomedical analysis
2011 744 925
Effect of topical morphine (mouthwash) on oral pain due to chemotherapy- and/or radiotherapy-induced mucositis: a randomized double-blinded studyJournal of palliative medicine
2010 773 0
The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodoneBritish journal of pharmacology
2010 877 2
Impact of genetic polymorphisms and drug-drug interactions on clopidogrel and prasugrel response variabilityCurrent drug metabolism
2010 674 0
Is a bird in the hand still worth two in the bush?European journal of anaesthesiology
2010 536 1
Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safetyBritish journal of pharmacology
2010 653 1
Uptake/efflux transport of tramadol enantiomers and O-desmethyl-tramadol: focus on P-glycoproteinBasic & clinical pharmacology & toxicology
2009 641 2
Douleurs chroniques et dépression: un aller-retour ?Revue médicale suisse
2009 692 0
Modulation cognitive et émotionnelle de la douleur: mécanismes de certaines approches cliniques révélés par les neurosciencesRevue médicale suisse
2009 737 12
Two-dimensional liquid chromatography-ion trap mass spectrometry for the simultaneous determination of ketorolac enantiomers and paracetamol in human plasma: application to a pharmacokinetic studyJournal of chromatography
2009 562 0
The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype predictionPharmacogenomics journal
2009 915 0
Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospitalDrug safety
2009 623 0
P-glycoprotein is not involved in the differential oral potency of naloxone and naltrexoneFundamental & clinical pharmacology
2009 677 0
Pharmacogenetics of analgesics: toward the individualization of prescriptionPharmacogenomics
2008 572 0
Influence of ABCB1 gene polymorphisms and P-glycoprotein activity on cyclosporine pharmacokinetics in peripheral blood mononuclear cells in healthy volunteersDrug metabolism letters
2008 861 0
Les toxidermies médicamenteusesRevue médicale suisse
2008 653 0
New approaches to the pharmacotherapy of neuropathic painExpert review of clinical pharmacology
2008 586 0
La prescription « off-label »Revue médicale suisse
2008 697 0
Lack of interaction of the NMDA receptor antagonists dextromethorphan and dextrorphan with P-glycoproteinCurrent drug metabolism
2008 655 4
Dexamethasone and risk of nausea and vomiting and postoperative bleeding after tonsillectomy in children: a randomized trialJAMA
2008 806 4
Prise en charge médicamenteuse de la douleur neuropathique : quelle place pour les traitements topiques?Revue médicale suisse
2008 425 0
Simultaneous quantification of cyclosporine, tacrolimus, sirolimus and everolimus in whole blood by liquid chromatography-electrospray mass spectrometryClinical biochemistry
2008 664 0
Quantification of cyclosporine and tacrolimus in whole blood. Comparison of liquid chromatography-electrospray mass spectrometry with the enzyme multiplied immunoassay techniqueClinical biochemistry
2008 660 1
Development and validation of a chemical hydrolysis method for dextromethorphan and dextrophan determination in urine samples: application to the assessment of CYP2D6 activity in fibromyalgia patientsJournal of chromatography. B
2008 626 4
Automédication chez les sans-papiers latino-américains : entre le nécessaire et l'inappropriéRevue médicale suisse
2007 421 0
Detecting drug interactions using personal digital assistants in an out-patient clinicQJM
2007 428 248
Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacologyExpert opinion on drug safety
2007 536 777
Quantification of cyclosporine A in peripheral blood mononuclear cells by liquid chromatography-electrospray mass spectrometry using a column-switching approachJournal of chromatography. B
2007 568 0
Emergency liver transplantation in amodiaquine-induced fulminant hepatitisThe American journal of tropical medicine and hygiene
2007 675 382
Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover studyClinical therapeutics
2007 770 0
Effets indésirables des inhibiteurs de la pompe à protons (IPP)Revue médicale suisse
2007 537 0
Anticoagulation orale et pharmacogénétique : perspectives pour la pratique cliniqueRevue médicale suisse
2007 409 0
Patients' representations of antidepressants: a clue to nonadherence?The Clinical journal of pain
2007 518 1
Prescription en médecine de premier recours: l'intérêt d'une liste de médicamentsRevue médicale suisse
2006 458 0
CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosisEuropean journal of clinical pharmacology
2006 661 580
Entre sel et gènes ou pharmacogénomique des antihypertenseursRevue médicale suisse
2006 413 0
Prise en charge médicamenteuse des troubles psychologiques et comportementaux lies à la démenceRevue médicale suisse
2006 485 0
Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factorsArchives of internal medicine
2006 491 433
Polymorphisme génétique et interactions médicamenteuses: leur importance dans le traitement de la douleurCanadian journal of anaesthesia
2005 551 488
Systemic allergic reaction and diffuse bone pain after exposure to a preparation of betamethasoneEuropean journal of internal medicine
2005 442 0
Sélection d'un médicament dans une classe thérapeutique donnée : l'exemple des «inhibiteurs de l'HMG-CoA réductase»Revue médicale suisse
2005 387 0
Le traitement de l'hypertension artérielle : un défi pour le praticienRevue médicale suisse
2005 474 0
SIADH consecutive to ciprofloxacin intakeEuropean journal of internal medicine
2004 488 2
Fibromyalgia: a randomised, controlled trial of a treatment programme based on self managementAnnals of the rheumatic diseases
2004 509 2
Influence du cycle mentruel sur le seuil de la douleur expérimentaleDouleur et analgésie
2004 607 1
QT interval prolongation in patients on methadone with concomitant drugsJournal of clinical psychopharmacology
2004 481 0
Codeine intoxication associated with ultrarapid CYP2D6 metabolismThe New England journal of medicine
2004 560 1
Neurophysiologic evidence for a central sensitization in patients with fibromyalgiaArthritis and rheumatism
2003 546 869
Clinical pharmacology and rationale of analgesic combinationsEuropean journal of anaesthesiology. Supplement
2003 400 0
Rofecoxib interaction with oral anticoagulant acenocoumarolEuropean journal of clinical pharmacology
2003 479 254
Advances with analgesics and NSAIDs for the treatment of spinal disordersBaillière's best practice & research. Clinical rheumatology
2002 491 674
Drug-induced epidermolysis bullosa acquisita with antibodies to type VII collagenJournal of the American Academy of Dermatology
2002 522 0
Hepatitis associated with Kava, a herbal remedy for anxietyBMJ. British medical journal
2001 663 468
Effet analgesique des opiaces en usage cutane: quelle est leur efficacite?Thérapie
2001 433 0
The tramadol optionEuropean journal of pain
2000 454 0
Contribution of cytochrome P-4502D6 phenotype to the neuromodulatory effects of dextromethorphanThe Journal of pharmacology and experimental therapeutics
1999 373 277
Anaphylactic shock induced by intraurethral use of chlorhexidineAllergy
1999 421 629
Use of the label "litigation neurosis" in patients with somatoform pain disorderGeneral hospital psychiatry
1998 475 223
Lack of acetaminophen ceiling effect on R-III nociceptive flexion reflexEuropean journal of clinical pharmacology
1998 537 0
Facteurs associes aux douleurs cancereuses refractairesSchweizerische medizinische Wochenschrift
1998 451 61
Sodium stibogluconate (pentostan) overdose in a patient with acquired immunodeficiency syndromeTherapeutic drug monitoring
1998 456 0
Influence du sexe sur la plainte douloureuseSchweizerische medizinische Wochenschrift
1998 440 0
Influences génétiques et environnementales sur la neuromodulation et l'effet antinociceptif du dextromethorphanSchweizerische medizinische Wochenschrift
1998 420 0
Rhabdomyolysis after correction of hyponatremia due to psychogenic polydipsia possibly complicated by clozapineThe annals of pharmacotherapy
1998 448 0
Pharmacologie du tramadolDrugs
1997 756 2
Stereoselective interaction between piroxicam and acenocoumarolBritish journal of clinical pharmacology
1996 647 7
Atteintes hepatiques medicamenteuses, il faut y penser !Schweizerische medizinische Wochenschrift
1996 353 0
Contribution of monoaminergic modulation to the analgesic effect of tramadolBritish journal of clinical pharmacology
1996 509 313
Systemic clonidine differentially modulates the abnormal reactions to mechanical and thermal stimuli in rats with peripheral mononeuropathyPain
1995 435 0
Influence of the sympathetic nervous system in the development of abnormal pain-related behaviours in a rat model of neuropathic painNeuroscience
1995 516 454
Time-course of nociceptive disorders induced by chronic loose ligatures of the rat sciatic nerve and changes of the acetylcholinesterase transport along the ligated nervePain
1994 505 0
Facteurs predictifs d'une resistance au traitement des douleurs neuropathiquesSchweizerische medizinische Wochenschrift
1994 408 0
Arret de travail et comportement-maladie chez des patients souffrant de douleurs chroniquesSchweizerische medizinische Wochenschrift
1994 477 0
Differential action of morphine and various opioid agonists on thermal allodynia and hyperalgesia in mononeuropathic ratsPain
1994 423 0
The pharmacology of tramadolDrugs
1994 493 0
Evaluation de la douleur chronique des patients d'age geriatriqueSchweizerische medizinische Wochenschrift
1994 501 0
Quelle posologie antalgique du paracetamol?Schweizerische medizinische Wochenschrift
1994 461 0
Pericardite recidivante induite par la mesalazine (5-ASA)Thérapie
1994 434 0
Opposite effects of axon damage on heat shock proteins (hsp 70) and ubiquitin contents in motor neurons of neuropathic ratsNeuroscience letters
1993 430 0
The highly selective delta agonist BUBU induces an analgesic effect in normal and arthritic rat and this action is not affected by repeated administration of low doses of morphineBrain research
1993 424 107
Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic painPain
1993 419 0
In vitro forecasting of drugs that may interfere with codeine bioactivationEuropean journal of drug metabolism and pharmacokinetics
1992 420 142
Impact of environmental and genetic factors on codeine analgesiaEuropean journal of clinical pharmacology
1991 425 0
Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI)Biochemical and biophysical research communications
1988 422 539
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack